178 related articles for article (PubMed ID: 27886677)
21. Testicular seminoma: a clinicopathologic and immunohistochemical study of 105 cases with special reference to seminomas with atypical features.
Tickoo SK; Hutchinson B; Bacik J; Mazumdar M; Motzer RJ; Bajorin DF; Bosl GJ; Reuter VE
Int J Surg Pathol; 2002 Jan; 10(1):23-32. PubMed ID: 11927966
[TBL] [Abstract][Full Text] [Related]
22. Global DNA methylation in fetal human germ cells and germ cell tumours: association with differentiation and cisplatin resistance.
Wermann H; Stoop H; Gillis AJ; Honecker F; van Gurp RJ; Ammerpohl O; Richter J; Oosterhuis JW; Bokemeyer C; Looijenga LH
J Pathol; 2010 Aug; 221(4):433-42. PubMed ID: 20593487
[TBL] [Abstract][Full Text] [Related]
23. Genomic and expression profiling of human spermatocytic seminomas: pathogenetic implications.
Looijenga LH; Stoop H; Hersmus R; Gillis AJ; Wolter Oosterhuis J
Int J Androl; 2007 Aug; 30(4):328-35; discussion 335-6. PubMed ID: 17573843
[TBL] [Abstract][Full Text] [Related]
24. The cancer/testis-antigen PRAME supports the pluripotency network and represses somatic and germ cell differentiation programs in seminomas.
Nettersheim D; Arndt I; Sharma R; Riesenberg S; Jostes S; Schneider S; Hölzel M; Kristiansen G; Schorle H
Br J Cancer; 2016 Aug; 115(4):454-64. PubMed ID: 27441500
[TBL] [Abstract][Full Text] [Related]
25. A c-KIT codon 816 mutation, D816H, in the testicular germ cell tumor: case report of a Japanese patient with bilateral testicular seminomas.
Tate G; Suzuki T; Kishimoto K; Mitsuya T
Acta Med Okayama; 2005 Feb; 59(1):33-6. PubMed ID: 15902997
[TBL] [Abstract][Full Text] [Related]
26. Distinguishing epigenetic features of preneoplastic testis tissues adjacent to seminomas and nonseminomas.
Gainetdinov IV; Kondratieva SA; Skvortsova YV; Zinovyeva MV; Stukacheva EA; Klimov A; Tryakin AA; Azhikina TL
Oncotarget; 2016 Apr; 7(16):22439-47. PubMed ID: 26843623
[TBL] [Abstract][Full Text] [Related]
27. DNA methylation profiles delineate epigenetic heterogeneity in seminoma and non-seminoma.
Brait M; Maldonado L; Begum S; Loyo M; Wehle D; Tavora FF; Looijenga LH; Kowalski J; Zhang Z; Rosenbaum E; Halachmi S; Netto GJ; Hoque MO
Br J Cancer; 2012 Jan; 106(2):414-23. PubMed ID: 22068818
[TBL] [Abstract][Full Text] [Related]
28. Differences in DNA methylation profiles by histologic subtype of paediatric germ cell tumours: a report from the Children's Oncology Group.
Williams LA; Mills L; Hooten AJ; Langer E; Roesler M; Frazier AL; Krailo M; Nelson HH; Bestrashniy J; Amatruda JF; Poynter JN
Br J Cancer; 2018 Oct; 119(7):864-872. PubMed ID: 30287918
[TBL] [Abstract][Full Text] [Related]
29. [KIT receptor in testicular seminoma].
Paule B
Prog Urol; 2005 Feb; 15(1):96-9; discussion 99. PubMed ID: 15822404
[TBL] [Abstract][Full Text] [Related]
30. TGF-β1, EGF and FGF4 synergistically induce differentiation of the seminoma cell line TCam-2 into a cell type resembling mixed non-seminoma.
Nettersheim D; Gillis AJ; Looijenga LH; Schorle H
Int J Androl; 2011 Aug; 34(4 Pt 2):e189-203. PubMed ID: 21649665
[TBL] [Abstract][Full Text] [Related]
31. Activated status of tumour-infiltrating lymphocytes and apoptosis in testicular seminoma.
Yakirevich E; Lefel O; Sova Y; Stein A; Cohen O; Izhak OB; Resnick MB
J Pathol; 2002 Jan; 196(1):67-75. PubMed ID: 11748644
[TBL] [Abstract][Full Text] [Related]
32. In-depth genomic data analyses revealed complex transcriptional and epigenetic dysregulations of BRAFV600E in melanoma.
Guo X; Xu Y; Zhao Z
Mol Cancer; 2015 Mar; 14():60. PubMed ID: 25890285
[TBL] [Abstract][Full Text] [Related]
33. Genome wide DNA methylation profiles provide clues to the origin and pathogenesis of germ cell tumors.
Rijlaarsdam MA; Tax DM; Gillis AJ; Dorssers LC; Koestler DC; de Ridder J; Looijenga LH
PLoS One; 2015; 10(4):e0122146. PubMed ID: 25859847
[TBL] [Abstract][Full Text] [Related]
34. Activating mutations and/or expression levels of tyrosine kinase receptors GRB7, RAS, and BRAF in testicular germ cell tumors.
McIntyre A; Summersgill B; Spendlove HE; Huddart R; Houlston R; Shipley J
Neoplasia; 2005 Dec; 7(12):1047-52. PubMed ID: 16354586
[TBL] [Abstract][Full Text] [Related]
35. Frequent epigenetic inactivation of p53 target genes in seminomatous and nonseminomatous germ cell tumors.
Christoph F; Kempkensteffen C; Weikert S; Krause H; Schostak M; Miller K; Schrader M
Cancer Lett; 2007 Mar; 247(1):137-42. PubMed ID: 16697107
[TBL] [Abstract][Full Text] [Related]
36. Detection of c-kit exons 11- and 17-activating mutations in testicular seminomas by high-resolution melting amplicon analysis.
Willmore-Payne C; Holden JA; Chadwick BE; Layfield LJ
Mod Pathol; 2006 Sep; 19(9):1164-9. PubMed ID: 16741525
[TBL] [Abstract][Full Text] [Related]
37. Distinctive epigenetic phenotype of cancer testis antigen genes among seminomatous and nonseminomatous testicular germ-cell tumors.
Zhang C; Kawakami T; Okada Y; Okamoto K
Genes Chromosomes Cancer; 2005 May; 43(1):104-12. PubMed ID: 15672408
[TBL] [Abstract][Full Text] [Related]
38. Microsatellite instability, mismatch repair deficiency, and BRAF mutation in treatment-resistant germ cell tumors.
Honecker F; Wermann H; Mayer F; Gillis AJ; Stoop H; van Gurp RJ; Oechsle K; Steyerberg E; Hartmann JT; Dinjens WN; Oosterhuis JW; Bokemeyer C; Looijenga LH
J Clin Oncol; 2009 May; 27(13):2129-36. PubMed ID: 19289622
[TBL] [Abstract][Full Text] [Related]
39. Genome-wide expression profiling reveals new insights into pathogenesis and progression of testicular germ cell tumors.
Biermann K; Heukamp LC; Steger K; Zhou H; Franke FE; Sonnack V; Brehm R; Berg J; Bastian PJ; Muller SC; Wang-Eckert L; Buettner R
Cancer Genomics Proteomics; 2007; 4(5):359-67. PubMed ID: 17993720
[TBL] [Abstract][Full Text] [Related]
40. Testicular germ-cell cancer.
Horwich A; Shipley J; Huddart R
Lancet; 2006 Mar; 367(9512):754-65. PubMed ID: 16517276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
